Clinical Assessment: 61-Year-Old Male on MHD with Post-Dialysis Abdominal "Stretching/Khich"

Understanding the Complaint

Most Likely Causes (Differential Diagnosis)

1. Uremic Gastroparesis / Delayed Gastric Emptying - MOST LIKELY

• Uremic toxins impair autonomic innervation of the GI tract
• Leads to delayed gastric emptying → bloating, fullness, early satiety
• Worsened by fluctuating fluid status during/after dialysis
• Common in 6-month MHD patients who may still have inadequate small-solute clearance

2. Constipation - VERY COMMON in MHD

• Caused by: restricted fluid and dietary intake, phosphate binders (calcium carbonate, sevelamer), oral iron supplements, potassium binders
• Can mimic or coexist with upper GI bloating
• Leads to pseudo-obstruction in severe cases

3. Intestinal Dysmotility / SIBO (Small Intestinal Bacterial Overgrowth)

• Uremia alters gut microbiome and motility
• Fermentation of undigested food → gas production → bloating
• Presents with flatulence, distension, discomfort

4. Peptic Ulcer Disease / Gastritis

• More common in dialysis patients than the general population
• Ulcers are often multilocular and postbulbar; pain may be absent
• However, PPI + H2 blocker failure suggests this is not the primary cause here

5. Inadequate Dialysis Clearance

• If Kt/V is suboptimal, uremic toxin accumulation worsens GI symptoms including anorexia, nausea, and distension
• Review dialysis adequacy parameters

6. Idiopathic Ascites (less common)

• Can occur in HD patients with high-protein ascitic fluid, related to inadequate dialysis dose

Recommended Investigations

Prescription / Management Plan

A. Add a Prokinetic Agent (First-Line for Gastroparesis/Dysmotility)

• Dose: 5 mg orally 30 minutes before meals (3 times daily)
• Note on renal dosing: Reduce dose by 50% in severe renal failure (use cautiously in ESRD - metoclopramide accumulates; start low, monitor for extrapyramidal effects)
• Maximum use: short-term (4-8 weeks), then reassess
• Watch for: tardive dyskinesia, drowsiness (especially in elderly)

B. Address Constipation

Avoid magnesium-containing laxatives in CKD/ESRD - risk of hypermagnesemia

C. Simethicone (Gas Relief)

• Simethicone 40-80 mg with meals and at bedtime
• Defoaming agent - reduces gas-related distension
• Safe in any degree of renal impairment (not absorbed)

D. Review and Rationalize Current Medications

• Stop duplicate acid suppression: Using both Pantoprazole (PPI) + Aciloc (ranitidine/H2 blocker) simultaneously is generally redundant and adds pill burden. Keep only the PPI (Pantoprazole 40 mg OD) if acid-related pathology is still suspected.
• Review phosphate binders: Consider switching from calcium carbonate to sevelamer if constipation is binder-related
• Check for oral iron - switch to IV iron (via dialysis session) to avoid GI side effects

E. Dialysis Prescription Optimization

• Check Kt/V - target ≥ 1.4 per session (3x weekly HD)
• Ensure adequate small-solute clearance
• If ascites is found: optimize dialysis dose, consider modality review

F. Dietary Advice

• Small, frequent, low-fat meals (improves gastric emptying)
• Limit high-fiber foods acutely (fiber can worsen bloating in dysmotility)
• Avoid carbonated drinks
• Post-dialysis ambulation / gentle walking helps GI motility

Summary Prescription Sheet

1. Tab Metoclopramide 5 mg PO, 30 min before meals (TDS) × 4 weeks
   [Reduce to 2.5 mg if drowsiness or extrapyramidal signs]

2. Tab Simethicone 80 mg with each meal + HS × 2 weeks

3. Lactulose syrup 15 mL BD OR PEG sachet OD (if constipation confirmed)

4. Tab Pantoprazole 40 mg OD before breakfast (STOP Aciloc - avoid dual acid blockade)

5. Review: IV iron instead of oral iron supplement during dialysis sessions

6. Dialysis: Review Kt/V, URR - optimize if suboptimal

7. AXR / USS abdomen if no improvement in 1 week

Red Flags Requiring Urgent Evaluation

• Abdominal rigidity or guarding → rule out perforation, intestinal ischemia
• Sudden worsening with vomiting and absent bowel sounds → pseudo-obstruction
• Blood in stools or hematemesis → GI hemorrhage (common in dialysis patients due to uremic hemostatic defects and angiodysplasia)
• Rapid weight gain + abdominal distension → ascites vs. fluid overload